Form 4: Gevo CFO Receives Equity Compensation Grant
Statement of Changes in Beneficial Ownership
Gevo, Inc. CFO Oluwagbemileke Yusuf was granted 304,878 shares of restricted stock and 352,258 stock options.
Summary
- CFO Oluwagbemileke Yusuf acquired 304,878 shares of restricted common stock on May 20, 2026.
- The CFO was also granted 352,258 stock options with an exercise price of $1.64 per share.
- Both the restricted stock and stock options vest in three equal annual installments starting on the first anniversary of the grant date.
- The reporting person's total direct beneficial ownership of common stock increased to 586,102 shares.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine administrative filing regarding executive compensation, which is neutral in terms of immediate market impact.
Positives
- Alignment of executive interests with long-term shareholder value through equity-based compensation.
- Retention of key financial leadership through multi-year vesting schedules.
Negatives
- Potential for future shareholder dilution upon the exercise of stock options and vesting of restricted stock.
Risks
- Continuous service requirement for vesting creates dependency on executive retention.
- Market price volatility may impact the ultimate value of the granted equity.
Future Outlook
The equity grants are subject to a three-year vesting schedule, contingent upon the CFO's continued service with the company.
Industry Context
StockSavvy.ai notes that equity-based compensation for C-suite executives is standard practice in the renewable chemicals and biofuels sector to incentivize long-term strategic execution.
Comparison to Industry Standards
- The use of three-year vesting schedules is consistent with standard corporate governance practices for executive compensation in the U.S. energy and technology sectors.
- Granting a mix of restricted stock and options is a common strategy to balance retention and performance-based incentives.
Stakeholder Impact
- Shareholders may experience minor dilution upon the eventual exercise or vesting of these equity instruments.
Next Steps
- Vesting of the first installment of restricted stock and options on May 20, 2027.
Key Dates
| Date | Description |
|---|---|
| 04/22/2026 | Date of 401(k) plan statement used for reporting. |
| 05/20/2026 | Date of the reported equity grant and transaction. |
| 05/22/2026 | Date of filing. |
| 05/19/2036 | Expiration date of the granted stock options. |
Keywords
Gevo, CFO, Equity Compensation, Insider Trading, Form 4, Stock Options, Restricted Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.